SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001297184-22-000021
Filing Date
2022-04-22
Accepted
2022-04-22 16:13:51
Documents
12
Period of Report
2022-04-19
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K amph-20220419x8k.htm   iXBRL 8-K 51855
  Complete submission text file 0001297184-22-000021.txt   170608

Data Files

Seq Description Document Type Size
2 EX-101.SCH amph-20220419.xsd EX-101.SCH 3288
3 EX-101.LAB amph-20220419_lab.xml EX-101.LAB 15455
4 EX-101.PRE amph-20220419_pre.xml EX-101.PRE 10479
6 EXTRACTED XBRL INSTANCE DOCUMENT amph-20220419x8k_htm.xml XML 4683
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 22845666
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences